GlassScriptPhysician profile
Robert K Dyer
NPI 1588866719
$2,525.23
in general payments reported to CMS, 2019-2025
21 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $701 · 2020: $311 · 2021: $224 · 2022: $161 · 2023: $325 · 2024: $478 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $283.50 | 2019-2024 | |
| Abbvie INC. | $283.12 | 2019-2024 | |
| Incyte Corporation | $260.88 | 2023 | Opzelura |
| Janssen Scientific Affairs, LLC | $231.29 | 2019-2022 | |
| Amgen INC. | $230.26 | 2020-2025 | Otezla |
| Galderma Laboratories, L.P. | $150.72 | 2021-2024 | |
| Leo Pharma INC. | $149.73 | 2019-2025 | Adbry |
| Novartis Pharmaceuticals Corporation | $121.56 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $118.96 | 2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $116.63 | 2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $94.31 | 2019-2020 | |
| Genzyme Corporation | $94.20 | 2019-2021 | |
| Ucb, INC. | $84.50 | 2024 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $61.34 | 2019-2021 | |
| Merz North America, INC. | $46.83 | 2019-2023 | Xeomin |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dusa Pharmaceuticals, INC. | $42.02 | 2019 | |
| Janssen Biotech, INC. | $38.50 | 2019-2020 | |
| Celgene Corporation | $38.47 | 2019 | |
| Mayne Pharma Commercial LLC | $34.60 | 2019 | |
| Genentech USA, INC. | $25.91 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.